Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 3, keine Gesamtzahl für „Adolescents“
Suchtreffer
Begriffe & Kennungen
Aripiprazole Zentiva · 4.8 · Mean changes in body weight in adolescents with Bipolar I Disorder at 12 and 30 weeks for aripiprazole were 2.
Eintrag öffnenAripiprazole Zentiva · 4.8 · Schizophrenia in adolescents aged 15 years and older In a short-term placebo-controlled clinical trial involvi
Eintrag öffnenAtectura Breezhaler · 4.8 · The safety profile of the medicinal product was assessed in the phase III study in adolescents (12 years and o
Eintrag öffnenAvamys · 4.8 · Epistaxis *Epistaxis was generally mild to moderate in intensity. In adults and adolescents, the incidence of
Eintrag öffnenAzarga · 4.8 · AZARGA is not recommended for use in children and adolescents below 18 years due to a lack of data on safety a
Eintrag öffnenAzomyr · 4.8 · Adults and adolescents At the recommended dose, in clinical trials involving adults and adolescents in a range
Eintrag öffnenBemrist Breezhaler · 4.8 · The safety profile of the medicinal product was assessed in the phase III study in adolescents (12 years and o
Eintrag öffnenBetmiga · 4.8 · Overall, the safety profile in children and adolescents is similar to that observed in adults.
Eintrag öffnenBetmiga · 4.8 · Overall, the safety profile in children and adolescents is similar to that observed in adults.
Eintrag öffnenBexsero · 4.8 · Adolescents (from 11 years of age) and adults
Eintrag öffnenBexsero · 4.8 · In adolescents and adults, the most common local and systemic adverse reactions observed were pain at the inje
Eintrag öffnenBiktarvy · 4.8 · Paediatric population The safety of Biktarvy was evaluated in 50 HIV-1 infected adolescents aged 12 to < 18 ye
Eintrag öffnenBimervax · 4.8 · Adolescents 12 through 17 years of age The most common adverse reactions reported after a booster dose of BIME
Eintrag öffnenBimervax · 4.8 · Adolescents 12 through 17 years of age The most common adverse reactions reported after a booster dose of BIME
Eintrag öffnenBimervax · 4.8 · Adolescents 12 through 17 years of age The most common adverse reactions reported after a booster dose of BIME
Eintrag öffnenBimervax · 4.8 · Adolescents 12 through 17 years of age The most common adverse reactions reported after a booster dose of BIME
Eintrag öffnenBimervax · 4.8 · Injection site induration, malaise, axillary pain and arthralgia occurred at higher frequencies in adolescents
Eintrag öffnenBimervax · 4.8 · Injection site induration, malaise, axillary pain and arthralgia occurred at higher frequencies in adolescents
Eintrag öffnenBimervax · 4.8 · Injection site induration, malaise, axillary pain and arthralgia occurred at higher frequencies in adolescents
Eintrag öffnenBimervax · 4.8 · Injection site induration, malaise, axillary pain and arthralgia occurred at higher frequencies in adolescents
Eintrag öffnen